FLOMENBERG NEAL (Chief Scientific Officer) sold 6.1% of their position (232.97K shares) of TEVOGEN BIO HOLDINGS INC. on the open market
Open‑market sale worth $253.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/14/2025ACC: 0001062993-25-005533
Officer· Chief Scientific Officer
Since Feb 2024
-232.97K
Net shares
Net seller
$253.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
232.97K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−232.97K
Price / share
$1.09
Trade value
$253.94K
% of position
6.1%
3/12/2025
3.83M→3.60M
Total
Net shares
−232.97K
Net value
-$253.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2025 | S · Sale | −232.97K | $1.09 | $253.94K | 6.1% | 3.83M | 3.60M |
| Total | −232.97K | -$253.94K | ||||||
Derivative Transactions0
No derivative transactions reported